SCHEMBL22494097

SCHEMBL22494097

CCCCCCCCCCCCCCCCCCCCCC(=O)NC(Cc1ccccc1)C(=O)O

nearest known ligand 0.81

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.81
ITGB3 P05106 2/20 0.65
ITGA2B P08514 2/20 0.65
PSMB5 P28074 2/20 0.64
HDAC3 O15379 1/20 0.60
HDAC4 P56524 1/20 0.60
HDAC1 Q13547 1/20 0.60
HDAC7 Q8WUI4 1/20 0.60
HDAC2 Q92769 1/20 0.60
HDAC10 Q969S8 1/20 0.60
HDAC11 Q96DB2 1/20 0.60
HDAC8 Q9BY41 1/20 0.60
HDAC6 Q9UBN7 1/20 0.60
HDAC9 Q9UKV0 1/20 0.60
HDAC5 Q9UQL6 1/20 0.60
NOD1 Q9Y239 1/20 0.58
EPHX2 P34913 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4066786 1.00 FAAH (0.81) FAAHITGB3ITGA2BPSMB5HDAC3
SCHEMBL9506671 1.00 FAAH (0.81) FAAHITGB3ITGA2BPSMB5HDAC3
SCHEMBL9716823 1.00 FAAH (0.81) FAAHITGB3ITGA2BPSMB5HDAC3
SCHEMBL1815009 1.00 FAAH (0.81) FAAHITGB3ITGA2BPSMB5HDAC3
SCHEMBL1815011 1.00 FAAH (0.81) FAAHITGB3ITGA2BPSMB5HDAC3
SCHEMBL9666114 1.00 FAAH (0.81) FAAHITGB3ITGA2BPSMB5HDAC3
SCHEMBL22494096 1.00 FAAH (0.81) FAAHITGB3ITGA2BPSMB5HDAC3
SCHEMBL22494095 1.00 FAAH (0.81) FAAHITGB3ITGA2BPSMB5HDAC3
SCHEMBL21998924 1.00 FAAH (0.81) FAAHITGB3ITGA2BPSMB5HDAC3
SCHEMBL15285319 1.00 FAAH (0.81) FAAHITGB3ITGA2BPSMB5HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11365177-B2 Chemical uncouplers of respiration and methods of use thereof DANA-FARBER CANCER INSTITUTE, INC. (US) 2022-06-21 US disclosed
US-20200317613-A1 CHEMICAL UNCOUPLERS OF RESPIRATION AND METHODS OF USE THEREOF UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED 2020-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11365177-B2 Chemical uncouplers of respiration and methods of use thereof PC, UQCRC1, SQOR FAAH 1063/4885ITGB3 4865/4885ITGA2B 4848/4885
US-20200317613-A1 CHEMICAL UNCOUPLERS OF RESPIRATION AND METHODS OF USE THEREOF PC, UQCRC1, SQOR FAAH 1063/4885ITGB3 4865/4885ITGA2B 4848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.